Trial
NCT01152255
MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Merck Sharp & Dohme LLC
Collaborators
—
Condition
HIV-1 Infection
Intervention
MK6186
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-23